Pharmaceuticals
Teva in talks to buy Allergan's generic-drug unit for $45 bn: report
27 Jul 2015
A deal with Allergan would indicate that Teva could be considering abandoning its plan to buy Mylan NV after the Netherlands-based company rejected its $40-billion takeover offer
Lupin buys US generics drug maker Gavis for $880 mn
23 Jul 2015
The cash-free and debt-free acquisition creates the fifth-largest portfolio of new drug filings with the US FDA, addressing a $63.8-billion market
Thoratec Corp accepts US heart device maker St Jude Medical's $3.4-bn offer
22 Jul 2015
The deal will accelerate St. Jude Medical’s growth strategy by adding Thoratec’s complementary products and technologies to its own portfolio of heart failure products
Horizon Pharma raises offer to buy Depomed to $33 per share
22 Jul 2015
Irish biopharmaceutical company Horizon Pharma Plc yesterday raised its offer to buy smaller US rival Depomed Inc to $33 per share in abid to nearly double its drugs portfolio
Valeant to buy Egyptian drugmaker Amoun for $800 mn
18 Jul 2015
Founded in 1998, Amoun is the largest pharmaceutical company in Egypt and expects to reach valuation of Egyptian £1.75 billion this year, with annual growth of approximately 20 per cent
.webp)
